Loading
A phase 3 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by Fudan University, not yet recruiting.
Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes is a phase 3, randomised interventional study registered as NCT07272109 by Fudan University, with a registry enrolment figure of 210 participants, started 2026-01-01 and due to reach its primary completion in 2027-12-30. Interventions recorded: Nab-paclitaxel; Gemcitabine (1000 mg/m2); Anti-Diabetics; Active treatment and monitoring. Conditions listed: Pancreatic Cancer. Primary outcome: Overall Survival (OS):. Pancreatic eligibility wording from the registry: "* Histologically or cytologically confirmed metastatic pancreas adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.